Tofacitinib, marketed under the brand name Xeljanz, is a medicine used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Common side effects include diarrhea, headaches, and high blood pressure. Serious side effects can include infection, cancer, and pulmonary embolism.